Written Question·Department of Health and Social Care·UIN 26370
Clozapine
Tabled: 24 January 2025
Answered: 3 February 2025
Question
Liz Jarvis
Liberal Democrat — Eastleigh
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the (a) efficacy of and (b) adequacy of the provision of Clozapine.
Answer
Karin SmythClozapine is licenced by the Medicines and Healthcare products Regulatory Agency (MHRA). Products are licenced by the MHRA where the benefit-risk assessment has been found to be positive in relation to quality, safety, and efficacy. Clozapine is marketed ...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 26370) →